|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| C07K 16/28 |
| (11) | Number of the document | 3616720 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19202367.9 |
| Date of filing the European patent application | 2018-03-28 | |
| (97) | Date of publication of the European application | 2020-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 2017065603 | 2017-03-29 | JP | |
| 2017185935 | 2017-09-27 | JP |
| (72) |
YOSHIDA, Tetsuya, JP
KIDANI, Yujiro, JP
MATSUMOTO, Mitsunobu, JP
KANAZAWA, Takayuki, JP
SHINONOME, Satomi, JP
HOJO, Kanji, JP
OHKURA, Naganari, JP
SAKAGUCHI, Shimon, JP
TANAKA, Atsushi, JP
WADA, Hisashi, JP
KAWASHIMA, Atsunari, JP
NONOMURA, Norio, JP
|
| (73) |
Shionogi & Co., Ltd.,
1-8, Doshomachi 3-chome Chuo-ku Osaka-shi, Osaka 541-0045,
JP
Osaka University, 1-1, Yamadaoka, Suita-shi, Osaka 565-0871, JP |
| (54) | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT |